Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · IEX Real-Time Price · USD
3.150
+0.120 (3.96%)
Mar 28, 2024, 2:40 PM EDT - Market open
RANI Market Cap
RANI has a market cap or net worth of $163.78 million as of March 28, 2024. Its market cap has decreased by -44.80% in one year.
Market Cap
163.78M
Enterprise Value
145.34M
1-Year Change
-44.80%
Ranking
Category
Stock Price
$3.15
Market Cap Chart
Since the IPO on July 30, 2021, RANI's market cap has decreased from $545.17M to $163.78M, a decrease of -69.96%. That is a compound annual growth rate of -36.37%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 152.00M | -4.70% |
Mar 26, 2024 | 159.50M | -1.73% |
Mar 25, 2024 | 162.30M | -0.73% |
Mar 22, 2024 | 163.50M | -9.47% |
Mar 21, 2024 | 180.60M | 0.84% |
Mar 20, 2024 | 179.10M | 0.90% |
Mar 19, 2024 | 177.50M | 6.29% |
Mar 18, 2024 | 167.00M | 0.78% |
Mar 15, 2024 | 165.70M | 6.22% |
Mar 14, 2024 | 156.00M | -6.31% |
Mar 13, 2024 | 166.50M | 8.12% |
Mar 12, 2024 | 154.00M | -9.41% |
Mar 11, 2024 | 170.00M | -10.29% |
Mar 8, 2024 | 189.50M | 3.27% |
Mar 7, 2024 | 183.50M | -1.08% |
Mar 6, 2024 | 185.50M | -1.07% |
Mar 5, 2024 | 187.50M | 1.08% |
Mar 4, 2024 | 185.50M | 0.54% |
Mar 1, 2024 | 184.50M | -1.34% |
Feb 29, 2024 | 187.00M | 9.04% |
Feb 28, 2024 | 171.50M | 0.29% |
Feb 27, 2024 | 171.00M | -0.87% |
Feb 26, 2024 | 172.50M | 4.23% |
Feb 23, 2024 | 165.50M | 1.53% |
Feb 22, 2024 | 163.00M | -0.31% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
scPharmaceuticals | 177.03M |
Sagimet Biosciences | 174.15M |
Aldeyra Therapeutics | 171.68M |
Telomir Pharmaceuticals | 170.19M |
OptiNose | 170.13M |
Nektar Therapeutics | 163.07M |
Syros Pharmaceuticals | 162.54M |
Lifecore Biomedical | 161.44M |